Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study

[1]  B. Korf,et al.  Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Elizabeth M. Wells,et al.  Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. , 2018, The Lancet. Oncology.

[3]  L. Messiaen,et al.  Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy , 2018, Journal of Medical Genetics.

[4]  K. North,et al.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis , 2018, Neuropsychology Review.

[5]  Y. T. Cheung,et al.  Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. , 2018, Journal of the National Cancer Institute.

[6]  M. Resnick.  Re: The Cumulative Burden of Surviving Childhood Cancer: An Initial Report from the St Jude Lifetime Cohort Study (SJLIFE). , 2018, The Journal of urology.

[7]  S. Peltonen,et al.  Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  I. Pollack,et al.  Nonrandomized comparison of neurofibromatosis type 1 and non–neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low‐grade glioma: A report from the Children's Oncology Group , 2016, Cancer.

[9]  F. Rivier,et al.  Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[10]  P. Nathan,et al.  Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. , 2016, The New England journal of medicine.

[11]  B. Biesecker,et al.  Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life , 2015, Clinical genetics.

[12]  A. Lovell,et al.  The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. , 2015, The Journal of pediatrics.

[13]  J. Østergaard,et al.  Teenagers and young adults with neurofibromatosis type 1 are more likely to experience loneliness than siblings without the illness , 2015, Acta paediatrica.

[14]  T. Vahlberg,et al.  Incidence and mortality of neurofibromatosis: a total population study in Finland. , 2015, The Journal of investigative dermatology.

[15]  J. Ragoussis,et al.  Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989 , 2013, European Journal of Human Genetics.

[16]  S. Huson,et al.  Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence , 2013, Developmental medicine and child neurology.

[17]  Grete Hummelvoll,et al.  Young Adults’ Experience of Living with Neurofibromatosis Type 1 , 2013, Journal of Genetic Counseling.

[18]  E. Jokinen,et al.  A controlled register‐based study of 460 neurofibromatosis 1 patients: Increased fracture risk in children and adults over 41 years of age , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Stephan C. J. Huijbregts,et al.  Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1? , 2010, Behavior genetics.

[20]  S. Huson,et al.  Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service , 2010, American journal of medical genetics. Part A.

[21]  G. Gioia,et al.  Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. , 2009, Neuropsychology.

[22]  Kevin R Krull,et al.  Social outcomes in the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Recklitis,et al.  Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  G. Gioia,et al.  Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire , 2008, Cancer.

[25]  A. Stanson,et al.  Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. , 2007, Journal of vascular surgery.

[26]  A. Crawford,et al.  The immature spine in type-1 neurofibromatosis. , 2007, The Journal of bone and joint surgery. American volume.

[27]  E. Boltshauser,et al.  Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. , 2006, The Journal of pediatrics.

[28]  D. Easton,et al.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK , 2006, British Journal of Cancer.

[29]  D. Evans,et al.  Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Kathryn N North,et al.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 , 2005, Neurology.

[31]  R. Packer,et al.  Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1 , 2005, Neurology.

[32]  Jan M Friedman,et al.  Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. , 2005, Archives of dermatology.

[33]  James R. Anderson,et al.  Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. , 2004, The Journal of pediatrics.

[34]  D. Evans,et al.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1 , 2002, Journal of medical genetics.

[35]  M. Denckla,et al.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. , 1997, Neurology.

[36]  J. Maris,et al.  Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. , 1997, Cancer.

[37]  A. Gilbert,et al.  Congenital pseudarthrosis of the tibia. Long-term followup of 29 cases treated by microvascular bone transfer. , 1995, Clinical orthopaedics and related research.

[38]  C. Stiller,et al.  Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. , 1994, British Journal of Cancer.

[39]  F. Collins,et al.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.

[40]  R. Cawthon,et al.  Somatic mutations in the neurofibromatosis 1 gene in human tumors , 1992, Cell.

[41]  S. Huson,et al.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. , 1989, Journal of medical genetics.